Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Inghirami

Showing results (31-40 of 239) with videos related to

Pageof 24
Sort By:
Plastic and Reconstructive Surgery|October 3, 2019
Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?Marshall E Kadin, William P Adams, Giorgio Inghirami, et al.
Oncotarget|March 5, 2016
Oncogenic kinase fusions: an evolving arena with innovative clinical opportunitiesFabrizio Tabbò, Marco Pizzi, Peter W Kyriakides, et al.
The American Journal of Pathology|October 15, 2019
Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell LymphomaSuzanne D Turner, Giorgio Inghirami, Roberto N Miranda, et al.
Molecular and Cellular Biology|November 6, 2002
In vivo interference with Skp1 function leads to genetic instability and neoplastic transformationRoberto Piva, Jian Liu, Roberto Chiarle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 19, 2002
Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival materialRuliang Xu, Mary Ann Perle, Giorgio Inghirami, et al.
Oncogene|July 26, 2002
Human rgr: transforming activity and alteration in T-cell malignanciesPeter Leonardi, Ezra Kassin, Inmaculada Hernandez-Muñoz, et al.
The Breast Journal|May 12, 2001
Tubular Carcinoma of the Breast: Immunohistochemical and DNA Flow Cytometric ProfileMaria Fasano, Eleftherios Vamvakas, Yara Delgado, et al.
Nature Medicine|May 13, 2008
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccinationRoberto Chiarle, Cinzia Martinengo, Cristina Mastini, et al.
Cell Cycle (Georgetown, Tex.)|August 6, 2005
New and old functions of STAT3: a pivotal target for individualized treatment of cancerGiorgio Inghirami, Roberto Chiarle, William J Simmons, et al.
Cancer Research|September 3, 2004
The Rgr oncogene induces tumorigenesis in transgenic miceMaría Jiménez, Ignacio Pérez de Castro, Marta Benet, et al.
Pageof 24

Showing results (31-40 of 239) with videos related to

Sort By:
Pageof 24
Plastic and Reconstructive Surgery|October 3, 2019
Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?Marshall E Kadin, William P Adams, Giorgio Inghirami, et al.
Oncotarget|March 5, 2016
Oncogenic kinase fusions: an evolving arena with innovative clinical opportunitiesFabrizio Tabbò, Marco Pizzi, Peter W Kyriakides, et al.
The American Journal of Pathology|October 15, 2019
Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell LymphomaSuzanne D Turner, Giorgio Inghirami, Roberto N Miranda, et al.
Molecular and Cellular Biology|November 6, 2002
In vivo interference with Skp1 function leads to genetic instability and neoplastic transformationRoberto Piva, Jian Liu, Roberto Chiarle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 19, 2002
Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival materialRuliang Xu, Mary Ann Perle, Giorgio Inghirami, et al.
Oncogene|July 26, 2002
Human rgr: transforming activity and alteration in T-cell malignanciesPeter Leonardi, Ezra Kassin, Inmaculada Hernandez-Muñoz, et al.
The Breast Journal|May 12, 2001
Tubular Carcinoma of the Breast: Immunohistochemical and DNA Flow Cytometric ProfileMaria Fasano, Eleftherios Vamvakas, Yara Delgado, et al.
Nature Medicine|May 13, 2008
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccinationRoberto Chiarle, Cinzia Martinengo, Cristina Mastini, et al.
Cell Cycle (Georgetown, Tex.)|August 6, 2005
New and old functions of STAT3: a pivotal target for individualized treatment of cancerGiorgio Inghirami, Roberto Chiarle, William J Simmons, et al.
Cancer Research|September 3, 2004
The Rgr oncogene induces tumorigenesis in transgenic miceMaría Jiménez, Ignacio Pérez de Castro, Marta Benet, et al.
Pageof 24